Dcf Advisers 13F annual report

Dcf Advisers is an investment fund managing more than $163 billion ran by David Floren. There are currently 67 companies in Mr. Floren’s portfolio. The largest investments include Micron Technology and Alphabet Inc, together worth $29.7 billion.

$163 billion Assets Under Management (AUM)

As of 8th May 2024, Dcf Advisers’s top holding is 159,500 shares of Micron Technology currently worth over $18.8 billion and making up 11.6% of the portfolio value. Relative to the number of outstanding shares of Micron Technology, Dcf Advisers owns more than approximately 0.1% of the company. In addition, the fund holds 71,650 shares of Alphabet Inc worth $10.9 billion, whose value grew 26.1% in the past six months. The third-largest holding is Regeneron Pharmaceuticals worth $10.2 billion and the next is Argenx Se worth $7.95 billion, with 20,200 shares owned.

Currently, Dcf Advisers's portfolio is worth at least $163 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Dcf Advisers

The Dcf Advisers office and employees reside in Greenwich, Connecticut. According to the last 13-F report filed with the SEC, David Floren serves as the Managing Member at Dcf Advisers.

Recent trades

In the most recent 13F filing, Dcf Advisers revealed that it had opened a new position in Baidu Inc and bought 19,250 shares worth $2.03 billion. This means they effectively own approximately 0.1% of the company. Baidu Inc makes up 4.2% of the fund's Technology sector allocation and has decreased its share price by 14.3% in the past year.

The investment fund also strengthened its position in Alphabet Inc by buying 1,500 additional shares. This makes their stake in Alphabet Inc total 71,650 shares worth $10.9 billion. Alphabet Inc soared 47.0% in the past year.

On the other hand, there are companies that Dcf Advisers is getting rid of from its portfolio. Dcf Advisers closed its position in Seagen Inc on 15th May 2024. It sold the previously owned 11,000 shares for $2.33 billion. David Floren also disclosed a decreased stake in Micron Technology by approximately 0.1%. This leaves the value of the investment at $18.8 billion and 159,500 shares.

One of the smallest hedge funds

The two most similar investment funds to Dcf Advisers are Friedenthal and Worth Asset Management. They manage $163 billion and $163 billion respectively.


David Floren investment strategy

Dcf Advisers’s portfolio is diversified across 9 sectors. Currently, their heaviest sector is Technology — making up 29.9% of the total portfolio value. The fund focuses on investments in the United States as 44.8% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 37% of the total holdings value. On the other hand, small-cap stocks make up only 3.0% of the portfolio. The average market cap of the portfolio companies is close to $170 billion.

The complete list of Dcf Advisers trades based on 13F SEC filings

These positions were updated on May 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Micron Technology Inc.
2.15%
159,500
$18,803,455,000 11.57%
Alphabet Inc
2.14%
71,650
$10,909,429,000 6.71%
Regeneron Pharmaceuticals, Inc.
2.53%
10,600
$10,202,394,000 6.28%
Argenx Se
8.18%
20,200
$7,953,144,000 4.89%
Advanced Micro Devices Inc.
6.63%
38,000
$6,858,620,000 4.22%
Intra-Cellular Therapies Inc
9.61%
96,857
$6,702,504,000 4.12%
Abbvie Inc
28.54%
31,800
$5,790,780,000 3.56%
Lilly Eli & Co
6.67%
7,000
$5,445,720,000 3.35%
Oracle Corp.
4.12%
40,750
$5,118,608,000 3.15%
Energy Transfer L P
17.09%
309,250
$4,864,503,000 2.99%
Bank America Corp
3.20%
125,350
$4,753,272,000 2.92%
Xencor Inc
15.15%
208,979
$4,624,705,000 2.85%
Spdr Gold Tr
2.33%
22,000
$4,525,840,000 2.78%
Ishares Gold Tr
No change
100,000
$4,201,000,000 2.58%
Incyte Corp.
15.73%
51,500
$2,933,955,000 1.81%
AMGEN Inc.
22.62%
10,300
$2,928,496,000 1.80%
Zimmer Biomet Holdings Inc
18.06%
21,719
$2,866,474,000 1.76%
Alibaba Group Hldg Ltd
79.81%
38,300
$2,771,388,000 1.71%
Prothena Corp Plc
28.99%
107,000
$2,650,390,000 1.63%
Apple Inc
No change
14,750
$2,529,330,000 1.56%
Turning Pt Brands Inc
No change
83,500
$2,446,550,000 1.51%
Ishares Tr
No change
24,000
$2,931,950,000 1.80%
Seagen Inc
Closed
11,000
$2,333,650,000
Nuveen Cr Strategies Income
1.19%
415,000
$2,311,550,000 1.42%
Aberdeen Total Dynamic Divd
3.16%
261,500
$2,167,835,000 1.33%
Baidu Inc
Opened
19,250
$2,026,640,000 1.25%
General Mtrs Co
20.45%
35,000
$1,587,250,000 0.98%
Lifecore Biomedical Inc
135.76%
284,684
$1,511,672,000 0.93%
VanEck ETF Trust
1.16%
61,200
$2,032,688,000 1.25%
Cisco Sys Inc
33.33%
30,000
$1,497,300,000 0.92%
Qualcom Inc
No change
8,500
$1,439,050,000 0.89%
O-I Glass Inc
44.73%
85,750
$1,422,593,000 0.88%
Ford Mtr Co Del
No change
100,000
$1,328,000,000 0.82%
Revance Therapeutics Inc
893.86%
263,372
$1,295,790,000 0.80%
Marvell Technology Inc
No change
17,500
$1,240,400,000 0.76%
Barrick Gold Corp.
38.10%
72,500
$1,206,400,000 0.74%
Teva Pharmaceutical Inds Ltd
91.01%
85,000
$1,199,350,000 0.74%
AT&T, Inc.
54.39%
65,000
$1,144,000,000 0.70%
Ishares Silver Tr
No change
50,000
$1,137,500,000 0.70%
EA Series Trust
31.67%
9,875
$1,051,293,000 0.65%
Spdr Ser Tr
Closed
13,500
$985,770,000
Altimmune Inc
19.80%
96,225
$979,571,000 0.60%
Meta Platforms Inc
No change
2,000
$971,160,000 0.60%
Srh Total Return Fund Inc
No change
59,000
$888,540,000 0.55%
Burford Cap Ltd
6.78%
55,000
$878,350,000 0.54%
Boeing Co.
120.00%
4,400
$849,156,000 0.52%
Intel Corp.
20.21%
18,750
$828,188,000 0.51%
Lensar Inc
15.68%
238,234
$809,281,000 0.50%
Teladoc Health Inc
Opened
51,400
$776,140,000 0.48%
Paypal Hldngs Inc
18.52%
11,000
$736,890,000 0.45%
Pan Amern Silver Corp
No change
45,000
$678,600,000 0.42%
Amazon.com Inc.
Closed
5,000
$635,600,000
Wolfspeed Inc
47.14%
20,600
$607,700,000 0.37%
Sanofi
11.11%
11,000
$534,600,000 0.33%
Pfizer Inc.
50.00%
19,250
$534,188,000 0.33%
Spotify Technology S.A.
No change
2,000
$527,800,000 0.32%
Lam Research Corp.
No change
500
$485,785,000 0.30%
YETI Holdings Inc
Opened
12,500
$481,875,000 0.30%
Citigroup Inc
No change
7,250
$458,490,000 0.28%
Samsara Inc.
Opened
10,000
$377,900,000 0.23%
Evotec Ag
2.55%
47,797
$374,251,000 0.23%
Alnylam Pharmaceuticals Inc
Closed
1,800
$318,780,000
Bristol-Myers Squibb Co.
Closed
5,250
$304,710,000
Palo Alto Networks Inc
Opened
1,000
$284,130,000 0.17%
Viridian Therapeutics Inc
7.41%
14,500
$253,895,000 0.16%
Johnson & Johnson
No change
1,500
$237,285,000 0.15%
Air T, Inc.
Closed
9,135
$204,167,000
Immunogen, Inc.
Closed
12,850
$203,930,000
Nokia Corp
70.85%
50,000
$177,000,000 0.11%
Paramount Global
Closed
12,500
$161,250,000
Lineage Cell Therapeutics In
30.21%
107,751
$159,471,000 0.10%
Arq Inc
Opened
16,000
$103,680,000 0.06%
Vir Biotechnology Inc
Closed
10,000
$93,700,000
Impel Pharmaceuticals Inc
Closed
178,500
$76,755,000
Kirklands Inc
27.87%
25,415
$61,250,000 0.04%
Ovid Therapeutics Inc
35.16%
19,730
$60,177,000 0.04%
Equillium Inc
Closed
69,871
$51,705,000
Amarin Corp Plc
5.74%
13,290
$11,839,000 0.01%
No transactions found
Showing first 500 out of 78 holdings